Column Group LLC
Follow13F filer, CIK 1833486, San Francisco, CA
Column Group LLC reported $88,100,083 across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-352333
- Period
- 2026-06-30
- Reported value
- $88.1M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001193125-26-352333, largest first. % of portfolio is the value over $88,100,083, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| Surrozen, Inc.Surrozen, Inc. | 1,916,950 | $49.7M | 56.46% | 0 | |||
| ORICORIC PHARMACEUTICALS INC | 3,540,777 | $38.3M | 43.53% | 0 | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 46 | $8.62K | 0.01% | 0 | Timeline |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-352333 | base | 2026-08-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-352333 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-227853 | Quarter ended 2026-03-31 | 2026-05-18 | acceptance time not in the bulk data set |